PUBLICATION

Comparative Antiseizure Analysis of Diverse Natural Coumarin Derivatives in Zebrafish

Authors
Kozioł, E., Jóźwiak, K., Budzyńska, B., de Witte, P.A.M., Copmans, D., Skalicka-Woźniak, K.
ID
ZDB-PUB-211116-11
Date
2021
Source
International Journal of Molecular Sciences   22(21): (Journal)
Registered Authors
de Witte, Peter
Keywords
behavior, coumarins, electrophysiology, epilepsy, pentylenetetrazole, zebrafish
MeSH Terms
  • 4-Aminobutyrate Transaminase/drug effects
  • Animals
  • Anticonvulsants/pharmacology*
  • Convulsants/pharmacology
  • Coumarins/pharmacology*
  • Epilepsy/drug therapy*
  • Mesencephalon/physiology
  • Pentylenetetrazole/pharmacology
  • Plant Extracts/pharmacology
  • Seizures/drug therapy*
  • Seizures/prevention & control
  • Zebrafish/physiology*
PubMed
34768849 Full text @ Int. J. Mol. Sci.
Abstract
Coumarins are a well-known group of plant secondary metabolites with various pharmacological activities, including antiseizure activity. In the search for new antiseizure drugs (ASDs) to treat epilepsy, it is yet unclear which types of coumarins are particularly interesting as a systematic analysis has not been reported. The current study performed behavioral antiseizure activity screening of 18 different coumarin derivatives in the larval zebrafish pentylenetetrazole (PTZ) model using locomotor measurements. Activity was confirmed for seven compounds, which lowered seizure-like behavior as follows: oxypeucedanin 38%, oxypeucedanin hydrate 74%, notopterol 54%, nodakenetin 29%, hyuganin C 35%, daphnoretin 65%, and pimpinellin 60%. These coumarins, together with nodakenin, underwent further antiepileptiform analysis by local field potential recordings from the zebrafish opticum tectum (midbrain). All of them, except for nodakenetin, showed pronounced antiepileptiform activity, decreasing PTZ-induced elevation in power spectral density (PSD) by 83-89% for oxypeucedanin, oxypeucedanin hydrate, and notopterol, 77% for nodakenin, 26% for nodakenetin, 65% for hyuganin C, 88% for daphnoretin, and 81% for pimpinellin. These data demonstrate the potential of diverse coumarin scaffolds for ASD discovery. Finally, the structural differences between active and inactive coumarins were investigated in silico for oxypeucedanin hydrate and byacangelicin for their interaction with GABA-transaminase, a hypothetical target.
Genes / Markers
Figures
Show all Figures
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Antibodies
Orthology
Engineered Foreign Genes
Mapping